Guess what! Tinea manus during interferon-alpha therapy for chronic hepatitis C.
Koga
T
T
Department of Dermatology, School of Medicine, Fukuoka University, Japan. tekoga@dermatol.med.kyushu-u.ac.jp
Shimizu
A
A
Kubota
Y
Y
Nakayama
J
J
Sohda
T
T
D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005385:Fingers; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D014005:Tinea / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy
D000935:Antifungal Agents; D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins